14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
TOON vs CURI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, CuriosityStream Inc. (CURI) is the stronger overall head-to-head candidate over Kartoon Studios, Inc. (TOON) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). TOON carries a Unified Composite Score of 33.5/100 (SELL) at $0.42 (123.5x Forward P/E, -42.5% operating margin), whereas CURI carries 52.8/100 (HOLD) at $2.54 (6.9x Forward P/E, 10.1% operating margin).
Technical & Structure Timing Caution: TOON is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 26.6); meanwhile CURI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 43.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Broadcasting value chain with $154.9M market capitalization and 10.1% operating margin.
OpEx & R&D Reinvestment50.1% of Rev ($39M)
90D Engineering Disclosures0 Published
Investor FAQ TOON vs CURI Key Questions & Quantitative Answers
As of Nov 20, 2026, CuriosityStream Inc. (CURI) is the stronger overall head-to-head candidate over Kartoon Studios, Inc. (TOON) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). TOON carries a Unified Composite Score of 33.5/100 (SELL) at $0.42 (123.5x Forward P/E, -42.5% operating margin), whereas CURI carries 52.8/100 (HOLD) at $2.54 (6.9x Forward P/E, 10.1% operating margin). Technical & Structure Timing Caution: TOON is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 26.6); meanwhile CURI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 43.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CURI leads the Growth & Scale pillar: TOON posts -45.7% YoY revenue growth and +0.0% YoY earnings growth on $28M TTM revenue (34.6% gross margin, -42.5% operating margin), compared with CURI at +12.9% YoY revenue growth and N/A YoY earnings growth on $78M TTM revenue (60.2% gross margin, 10.1% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), TOON cumulative revenue shifted +300.0% while CURI shifted +250.0%. In operating R&D and SG&A reinvestment, TOON deploys 77.1% of Rev ($22M) (0 90-day corporate R&D disclosures) versus 50.1% of Rev ($39M) (0 disclosures) for CURI.
TOON screens cheaper on headline valuation multiples. TOON trades at 123.5x Forward P/E, 3.1x Trailing P/E, N/M PEG, and 1.3x EV/Revenue (93.1% FCF margin), whereas CURI trades at 6.9x Forward P/E, 17.4x Trailing P/E, N/M PEG, and N/M EV/Revenue (31.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TOON (26.4% ROE) versus CURI (19.3% ROE) capital efficiency.
In options market volatility and institutional positioning, TOON carries 313.3% implied volatility (51st %ile, Balanced (25th–60th %ile)), a 1.66x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (0.90β · 43% Vol realized risk). By comparison, CURI carries 67.6% implied volatility (3rd %ile, Compressed (<25th %ile)), a 0.93x (Balanced) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.36β · 99% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.